Model Antigens

Diallo J.S. et al. (2020). Oncolytic Rhabdovirus Vaccine Boosts Chimeric Anti-DEC205 Priming for Effective Cancer Immunotherapy. Molecular Therapy Oncolytics. doi: 10.1016/j.omto.2020.10.007

Arnaboldi P.M. et al. (2009). Suppression of Th1 and Th17, but not Th2, responses in a CD8+ T cell-mediated model of oral tolerance. Mucosal Immunology. doi: 10.1038/mi.2009.93

Adriouch S. et al. (2011) Improved Immunological Tolerance Following Combination Therapy with CTLA-4/Ig and AAV-Mediated PD-L1/2 Muscle Gene Transfer. Frontiers in Microbiology. doi: 10.3389/fmicb.2011.00199